<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-A
For Registration of Certain Classes of Securities
Pursuant to Section 12(b) or (g) of the
Securities Exchange Act of 1934
ENDOCARDIAL SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 41-1724963
(State of incorporation (I.R.S. Employer
or organization) Identification No.)
1350 ENERGY LANE, SUITE 110
ST. PAUL, MINNESOTA 55108
(Address of principal executive offices) (Zip Code)
If this Form relates to the registration of a class of debt securities and is
effective upon filing pursuant to General Instruction A.(c)(1), please check the
following box. / /
If this Form relates to the registration of a class of debt securities and is to
become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A.(c)(2), please check the following box. / /
Securities to be registered pursuant to Section 12(b) of the Act:
Not Applicable
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 par value Nasdaq National Market
(Title of class) (Name of each exchange on which each
class is to be registered)
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED
On January 29, 1997, Endocardial Solutions, Inc. (the "Company") filed a
Registration Statement registering 3,450,000 shares of its Common Stock, $.01
par value, on Form S-1 (File No. 333-20677) (the "Registration Statement") with
the Securities and Exchange Commission under the Securities Act of 1933, as
amended. This summary description of the Company's Common Stock is qualified in
its entirety by reference to the Registration Statement, which is hereby
incorporated herein by reference.
ITEM 2. EXHIBITS
3.1 Articles of Incorporation, as amended (incorporated by reference to Exhibit
No. 3.2 to the Company's Registration Statement on Form S-1 (Registration
No. 333-20677)).
3.2 Bylaws, as amended (incorporated by reference to Exhibit No. 3.3 to the
Company's Registration Statement on Form S-1 (Registration No. 333-20677)).
4.1 Specimen Form of the Common Stock Certificate (incorporated by reference to
Exhibit No. 4.1 to the Company's Registration Statement on Form S-1
(Registration No. 333-20677)).
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereto duly authorized.
ENDOCARDIAL SOLUTIONS, INC.
Date: March 17, 1997
By /s/ James W. Bullock
-----------------------
James W. Bullock
President and Chief Executive Officer
-3-
<PAGE>
EXHIBIT INDEX
-------------
EXHIBIT DESCRIPTION OF EXHIBIT
- ------- ----------------------
3.1 Articles of Incorporation, as amended (incorporated by reference to
Exhibit No. 3.2 to the Company's Registration Statement on Form S-1
(Registration No. 333-20677)).
3.2 Bylaws, as amended (incorporated by reference to Exhibit No. 3.3 to
the Company's Registration Statement on Form S-1 (Registration No.
333-20677)).
4.1 Specimen Form of the Common Stock Certificate (incorporated by
reference to Exhibit No. 4.1 to the Company's Registration Statement
on Form S-1 (Registration No. 333-20677)).
-4-
